Sanimed's 2025: A Year of Resilience and Preparation for Future Growth
For Sanimed, 2025 was a true test of endurance, marked by financial tensions and necessary operational adjustments. The sanitary specialist saw its activity slow down, but this decline is not an end in itself. On the contrary, the company took advantage of these challenging months to lay the foundations for its future growth and prepare for a solid rebound.
Key Figures
Sanimed closed the year with a global turnover of 28.4 million dinars, representing a 13% decline compared to the previous year. This slowdown does not reflect a lack of interest from customers, but rather logistical difficulties, including cash flow constraints that hindered the company's ability to fulfill several firm international orders.
The Paradox of the Local Market
In Tunisia, the turnover dropped by 16% (from 19.2 to 16.1 million dinars). This is not a demand problem, but rather a supply issue. Absorbed by its financial restructuring and hindered by production interruptions, the factory was unable to provide enough finished products to meet the demand of the local market.
Notable Resilience in Exports
Despite this context, international activity has shown encouraging resilience. The export turnover has only declined by 9%, reaching 12.3 million dinars. This is a solid performance, especially considering that Sanimed had to navigate production delays and new import restrictions in the Algerian market.
Heading into 2026
While the 2025 financial report shows an increase in bank commitments (+4%), the future looks more promising. The company's order book remains solid, with strong demand. Sanimed is already in advanced discussions to strengthen its presence in Italy and Libya. A significant capital increase (from 16.5 to 26.6 million dinars) has been implemented, and its concrete benefits are expected to be felt in 2026.
Conclusion
Once the debt restructuring is complete, Sanimed expects a gradual increase in power, in line with its ambitious business plan for 2026-2030. In summary, if 2025 was a year of resistance, Sanimed seems to have taken advantage of this period to consolidate its structure and prepare for a rebound in the next fiscal year.
